Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CHANDRA BHAGAT PHARMA LTD.

NSE : NABSE : 542934ISIN CODE : INE07QQ01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE57.950 (0 %)

PREV CLOSE ( ) 57.95

OPEN PRICE ( ) 58.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2000

TODAY'S LOW / HIGH ( )57.95 58.00

52 WK LOW / HIGH ( ) 46.1585.5

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-03 2003

Management Info

Hemant Chandravadan Bhagat - Chairman Hemant Chandravadan Bhagat - Managing Director

Registered Office

Address Flat No. 1 & 2, Gr. Floor, 323,F, Bhagat Bhuvan Dr. Ambedkar Road,Matunga (East),
Mumbai,
Maharashtra-400019

Phone 022-24146154 / 24157205 / 24129162

Email info@cbcpharma.net, export@cbcpharma.net

Website www.cbcpharma.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE

NEWS

21Apr Chandra Bhagat Pharma informs about c
Chandra Bhagat Pharma has informed that, as per Regulation 15 of SEBI (L..

18Nov Chandra Bhagat Pharma informs about pr
Chandra Bhagat Pharma has informed that the 18th Annual General Meeting..

21Oct Chandra Bhagat Pharma informs about ou
Chandra Bhagat Pharma has informed that the Board of Directors of the Co..

01Oct Chandra Bhagat Pharma informs about cl
In Accordance with code of Internal Procedure and Conduct of Regulating,..

22Jun Chandra Bhagat Pharma informs about bo
Chandra Bhagat Pharma has informed that meeting of the Board of Director..

Financials

Rs. in Millions

	QTR	ANNUAL 25
Net Profit		8.56999999999999
Gross Profit		11.65
Operating Profit		40.64
Net Sales		867.16

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 15298.90 (4.78%)	M.Cap ( in Cr)19628.32
Alkem Laboratories (BSE) 4933.45 (1.92%)	M.Cap ( in Cr)58986.79
Bharat Parenterals (BSE) 1573.40 (5.00%)	M.Cap ( in Cr)1084.38
Fredun Pharma (BSE) 965.10 (7.76%)	M.Cap ( in Cr)455.69
NGL Fine-Chem (BSE) 1373.40 (5.00%)	M.Cap ( in Cr)848.49

Shareholding Pattern

	PROMOTERS	71.2%
	NON-INSTITUTION	28.19%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

CHANDRA BHAGAT PHARMA LTD.